PSN Survey 2010
PSN Survey 2010
GASTROINTESTINAL INVOLVEMENT IN THE POST POLIO SYNDROME (PPS)
Sinn Anuras, M.D.
This study has not been published by a peer-reviewed Journal — or on the Internet until now, except for America Online. Tom Walter put together this article from talks the Dr. gave about it in the early ’90’s, plus feedback he gave to some local
participants.
BACKGROUND
During the late 1980’s to early 1990’s, Dr. Anuras was Director, Division of Gastroenterology, Department of Internal Medicine at Texas Tech University in Lubbock. Along with Terri Bozeman, R.N., they surveyed over 750 post-polio patients regarding their gastrointestinal symptoms. Following report is from a paper they delivered at The Second Texas-Oklahoma Post-Polio Symposium, September 21-22, 1991, at the Ramada Inn of Wichita Falls, TX.
(To that point, they had included 500 patients in the results; Table 3 below has been updated to reflect the symptoms of the first 754 participants in the study.)
ABSTRACT
Gastrointestinal involvement is common in the post-polio syndrome, and it appears to affect the entire gastrointestinal tract. Unfortunately, there are only a few studies in this fascinating area. More extensive studies are needed to understand the pathologic and pathophysiologic processes in this problem, so that patients can be treated properly.
We report our survey of gastrointestinal symptoms that could affect up to 50 per cent of the post polio syndrome patients in this review. We also propose the underlying pathophysiologic changes, outline the diagnosis and treatment for difficulties of various parts of the gastrointestinal tract.
INTRODUCTION
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 1 of 10
Normal gastrointestinal motility is a function of the gastrointestinal smooth muscle and is regulated by both the intrinsic (myenteric plexus) and extrinsic nerves of the gastrointestinal tracts. Extrinsic nerves from the central nervous system (brain and spinal cord) connect the enteric nervous system (submucosal plexus and myenteric plexus) with the central nervous system. Therefore, any functional or structural abnormality of either the smooth muscles or the intrinsic or extrinsic nerves will result in gastrointestinal dysmotility causing gastrointestinal symptoms.
The symptoms produced depend on areas of involvement. This abnormality may either involve the entire gastrointestinal tract or be limited only to certain parts depending on the underlying disease. Table 1 lists various causes of neuromuscular disease of the gastrointestinal tract that can cause gastrointestinal dysmotility by extrinsic denervation to certain parts of the gastrointestinal tract.
TABLE 1
CAUSES OF NEUROMUSCULAR DISEASE OF THE GASTROINTESTINAL TRACT A. SMOOTH MUSCLE DISEASE
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 2 of 10
Results from our survey suggest that PPS may also cause damage to the intrinsic nerve (myenteric plexus) of the gastrointestinal tract. Future physiologic and pathologic studies of the gastrointestinal tract in PPS will elucidate these abnormalities.
Symptoms produced by gastrointestinal dysmotility are variable depending on the part of the gastrointestinal tract involved. Table 2 lists symptoms produced by dysmotility of certain parts of the gastrointestinal tract. We can see that there are a variety of symptoms that can be caused by gastrointestinal dysmotility. Thus, patients with the same disease may have different complaints that may appear to be unrelated. Patients with PPS may have difficulty with swallowing and constipation, and both symptoms can be caused by PPS.
TABLE 2
SYMPTOMS PRODUCED BY DYSMOTILITY OF VARIOUS PARTS OF THE GASTROINTESTINAL TRACT
| ORGANS | SYMPTOMS | |
| 1. Oropharynx | Difficulty initiating swallows, food pooling in the pharynx, choking when swallowing, aspiration and aspirated pneumonia in severe cases. | |
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 3 of 10
| 2. | Esophagus | Difficulty swallowing (dysphagia), food sticking in the mid-sternum area, occasional substernal pain with swallows (odynophagia). |
| 3. Stomach | Nausea, vomiting, abdominal fullness long after meal, recurrent symptoms of stomach outlet obstruction (gastroparesis). | |
| 4. | Small
intestine |
Abdominal pain and bloating after meal, nausea, vomiting, diarrhea, recurrent symptoms of small bowel obstruction in severe cases (intestinal pseudoobstruction). |
| 5. Colon | Constipation, abdominal pain and bloating, recurrent symptoms of colonic obstruction in severe cases (colonic pseudoobstruction). | |
| 6. Anus | Constipation. |
GASTROINTESTINAL INVOLVEMENT IN PPS
There are only a few studies of gastrointestinal involvement in polio survivors, and all are limited to oropharyngeal dysphagia. Gastrointestinal involvement has been virtually neglected by physicians who take care of PPS patients. We surveyed the nature and incidence of gastrointestinal symptoms in PPS patients by sending out questionnaires to 3,000 PPS patients. Table 3 lists the symptoms that we analyzed from the first 754 PPS patients who responded to our survey.
TABLE 3
GASTROINTESTINAL SYMPTOMS OF 754 PATIENTS
| INCIDENCE PER CENT | SYMPTOMS | ORGANS INVOLVED |
| 24 | Difficulty Initiating Swallow | Oropharynx |
| 32 | Choking with Swallowing | Oropharynx |
| 32 | Difficulty Swallowing (dysphagia) Esophagus | |
| 51 | Heartburn | Esophagus |
| 28 | Nausea | Stomach, Small Intestine |
| 12 | Vomiting | Stomach, Small Intestine |
| 53 | Abdominal Bloating | Stomach, Small Intestine, Colon |
| 40 | Abdominal Pain | Small Intestine, Colon |
| 32 | Diarrhea | Small Intestine, Colon |
| 48 | Constipation | Colon, Anorectum |
| 0.7 | Intestinal pseudoobstruction | Small Intestine |
The results from our survey suggested that gastrointestinal symptoms are common and extensive in PPS patients. These gastrointestinal symptoms may be caused by extensive gastrointestinal
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 4 of 10
dysmotility from the oropharynx to the colon. To understand the pathophysiology and pathology, we need to study the motility and histology of the esophagus, stomach, small intestine and the colon of PPS patients. Full thickness biopsies of bowel wall from surgical or autopsy specimens will enable us to examine the neuromuscular apparatus of the gastrointestinal tract in these patients.
DIAGNOSTIC WORK-UPS FOR GASTROINTESTINAL SYMPTOMS IN PPS PATIENTS
Since our survey showed extensive involvement of the gastrointestinal symptoms, the diagnostic work-ups must be directed to the patients’ complaints (see Table 3). Table 4 lists the work-ups for various parts of the gastrointestinal tract.
TABLE 4
DIAGNOSTIC WORK-UPS FOR GASTROINTESTINAL ORGANS IN PPS PATIENTS
| ORGANS | DIAGNOSTIC TESTS | |||
| Oropharynx (1) Video esophagram, | (2) Upper esophageal sphincter manometry. | |||
| Esophagus | (1) Barium
esophagram, |
(2) Esophageal manometry. | ||
| Stomach | (1) Upper
gastrointestinal x-rays, |
(2) Radionuclide gastric emptying study. | ||
| Small
intestine |
(1) Plain abdominal x rays, | (2) Small bowel x-rays, | (3) Small intestinal manometry. | |
| Colon | (1) Plain abdominal x rays, | (2) Barium
enema, |
(3) Radio-opaque
markers study, |
(4) Colonic
manometry. |
| Anus | (1) Anorectal manometric study. | |||
If the complaints are oropharyngeal symptoms, video or cine-esophagram is useful to evaluate the swallowing mechanism of the patients. The abnormalities include unilateral bolus transport through the pharynx, pooling in the valleculae or pyriform sinuses, delayed pharyngeal contraction, and impaired tongue movements. Upper esophageal sphincter manometry may show incoordination between upper esophageal sphincter relaxation and pharyngeal contraction during swallowing.
Work-up for esophageal dysmotility includes barium esophagram and esophageal manometric study. Barium esophagram will rule out esophageal obstruction as a cause of dysphagia, and it will enable us to evaluate the diameter of the esophagus, gastroesophageal reflux and contractile activities of the esophagus. Esophageal manometric study will detect any motility disorder of the esophagus. The standard esophageal manometric technique uses low compliance water perfusion system through an esophageal manometric tube.
To evaluate gastric dysmotility, we obtain upper gastrointestinal (UGI) x-rays and radionuclide gastric emptying study. UGI x-rays will enable us to detect any ulcer or outlet obstruction that may
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 5 of 10
mimic gastric dysmotility. Radionuclide gastric emptying study using technetium-labelled scrambled egg will quantitate the emptying function of the stomach. In normal subjects, half of the solid contents will empty from the stomach in 45-90 minutes. If there is a delay in gastric emptying, it will take longer than 90 minutes for half of the solid contents to empty from the stomach. Radionuclide gastric emptying study is an excellent objective method to measure the stomach emptying function.
Abdominal bloating and distention may develop in patients with intestinal and colonic dysmotility. Plain abdominal x-rays are useful to detect gaseous distention of the dysfunctional organs. The patients may have ileus of the small intestine or colon due to severe dysmotility causing symptoms and signs of bowel obstruction without any evidence of mechanical obstruction. (It is called intestinal pseudoobstruction or colonic pseudoobstruction depending on the organ involved.)
Small intestinal dysmotility can be evaluated by small bowel x-rays and small intestinal manometric study. Small bowel x-rays enable us to rule out organic disease, to evaluate the size and contractility of the small bowel, and to measure the barium transit time of the small bowel. Small intestinal manometric study will detect any abnormal motility of the small intestine. During fasting, the small intestine has a unique pattern of motility called migrating motor complex (MMC).
MMC has three phases. Phase 1 is a quiescent period lasting for 10-15 minutes. It is followed by phase 2 which shows intermittent contractions that last for 60-90 minutes. The contractions will intensify with time and will reach phase 3 when the small intestine contracts intensely at approximately 11-13 times per minute. Phase 3 lasts for 5-8 minutes, and the small intestine becomes quiescent again, i.e., it returns to phase 1.
This cyclical motor activity will go on until the subjects are fed. After feeding, the subjects will have fed activity which resembles active phase 2. The fed activity does not have any cyclical motor activities. Fed activity usually lasts for 4-5 hours and the small intestine will return to fast pattern after that. Any small intestinal dysmotility will cause alteration of the above activities. Small intestinal manometry is very sensitive to detect abnormality in patients with small bowel dysmotility.
To evaluate colonic dysmotility, we use barium enema, radio-opaque markers study and colonic manometric study. Barium enema will enable us to rule out any organic lesion and to evaluate the size and length of the colon. Radio-opaque markers study will determine if colonic dysmotility is caused by colonic inertia or functional colonic outlet obstruction. Colonic manometric study will detect colonic dysmotility.
Function of the anorectal area can be evaluated by anorectal manometry. In normal subjects, the internal anal sphincter relaxes when the rectum is distended. If the patients lose this reflex, they will have constipation.
As we can see from the above discussion, there are specific diagnostic work-ups for certain parts of the gastrointestinal tract. A careful history will direct us to study the appropriate organs. From the
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 6 of 10
survey, it appears that gastrointestinal dysmotility in PPS patients can affect the entire gastrointestinal tract. Therefore, taking a good history from the patients is important to direct us to give appropriate diagnostic work-ups.
TREATMENT
Treatment must be directed to the patients’ problems. We will discuss the treatment of dysmotility of each organ separately.
(1) oropharyngeal dysmotility.
The most serious complication of oropharyngeal dysmotility is aspiration during swallowing. The treatment must focus on the prevention of aspiration that may lead to aspiration pneumonia. Pharmacologic treatment has not been very effective. In patients who are less symptomatic, taking the time to eat or drink will reduce the incidence and severity of choking and aspiration. Dilatation of the cricopharyngeus muscle with bougies can be tried in more symptomatic patients. However, the effectiveness of the dilatation is not proven. It might be worthwhile to try before embarking on more invasive therapy.
In patients who have severe aspiration and recurrent aspiration pneumonia, cricopharyngeal myotomy should be considered. The technique involves sectioning the fibers of the cricopharygeus down to the submucosa; and it can even be done under local anesthesia in poor-risk patients. Two thirds of the patients operated upon have been relieved of dysphagia. There are a small number of patients who develop massive aspiration after cricopharyngeal myotomy. We strongly believe that any patients who undergo cricopharyngeal myotomy require esophageal manometric study and gastric emptying study.
Esophageal manometric study will allow us to evaluate the competency of the lower esophageal sphincter; the competency will help to prevent gastroesophageal reflux. Gastric emptying study will allow us to detect any delay in gastric emptying that may promote gastroesophageal reflux and aspiration. Abnormality of any of these two tests may exclude the patients from having cricopharyngeal myotomy.
(2) Esophageal dysmotility.
The treatment for dysphagia due to abnormal motility has not been effective. Calcium channel blockers (such as nifedipine), nitroglycerine and balloon dilatation of the lower esophageal sphincter may be useful in some patients with diffuse esophageal spasm due to intrinsic nerve dysfunction of the esophagus. At least half of the patients with diffuse esophageal spasm do not respond to the above regimens.
In patients with gastroesophageal reflux and heartburn, antireflux regimen must be used to prevent complications of reflux esophagitis and stricture formation. We give a dose of H2 receptor antagonists such as Tagamet, Zantac, or Pepcid before bedtime, and elevate the head of the bed
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 7 of 10
approximately 6 inches.
(3) Gastric dysmotility.
Delayed gastric emptying usually occurs with gastric dysmotility. Metoclopramide has been used to treat this problem with variable results. A liquid and low fat meal empties faster from the stomach than a solid meal. Therefore, we advise the patients to take a low fat and liquid meal. Feeding formula such as Ensure, Vivonex, Isocal and so on can be used to supplement the calories.
A new prokinetic drug, cisapride, is being studied for delayed gastric emptying. Early results are encouraging. When this drug is available in the market, it will be useful for this group of patients.
(4) Small intestinal dysmotility.
Small intestinal dysmotility may cause postprandial (after eating) abdominal pain and bloating. In severe cases, the patients may have intestinal obstructive symptoms and signs. There has been no effective prokinetic drug available yet for this problem. An ideal prokinetic drug should either enhance the contraction of a damaged muscle or normalize the coordination of a damaged myenteric plexus. No drug has, as yet, lived up to this expectation.
The symptoms in most patients occur intermittently, and only a small number of patients may have persistent symptoms. Since the symptoms are directly related to meals, manipulating the amount, the nature and the frequency of meals may help some patients. The patients should consume 25 calories/kg of ideal body weight per day divided into 3-4 equal amounts. Half of the calories may come from feeding formulas. The patients must avoid carbonated beverages to prevent adding excessive gas in the digestive tract.
Occasionally, nasogastric suction and intravenous fluid are needed when the patients have intestinal obstructive symptoms. When the obstructive symptoms are persistent or occur several times a week, a long term parenteral nutrition is the only treatment that will improve the patient’s symptoms and nutritional status.
(5) Colonic dysmotility.
The most common complaint is chronic constipation. The patients must avoid using stimulant laxatives such as Senokot, Dulcolax, etc., on a long term basis because most of the stimulant laxatives can damage the myenteric plexus when using them long term. This effect will further compound the difficulty that the patient already has.
We usually try the patients on high fiber diets or fiber compounds such as Fibercon or Metamucil. More than half of the patients will respond to these regimens. If the patients do not respond to fiber, we next try to use saline laxatives such as milk of magnesia. We titrate the dose of milk of magnesia to obtain one bowel movement a day. In early stages, it is not uncommon to use milk of magnesia up to two ounces per day. Later on, we are usually able to maintain the patients on one tablespoon daily. Tap water enema can be used if the patients have no bowel movement for three
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 8 of 10
days while on fiber or milk of magnesia.
In patients with obstipation despite adequate dose of fibers or milk of magnesia, an ileostomy or subtotal colectomy with ileoproctostomy may be required to take care of the problem. We encounter very few patients with colonic dysmotility with severe obstipation that require such a drastic approach.
(6) Anorectal dysfunction.
At the present time, we are not certain if PPS patients have any anorectal dysfunction. Anorectal manometric study in these patients will enable us to better understand the anorectal function in this group of patients. The medical treatment of anorectal dysfunction is disappointing. Surgical treatment such as rectal myectomy may be beneficial to some patients with anorectal dysfuntion.
The Lincolnshire Post-Polio Network
Registered Charity No. 1064177
An Information Service for Polio Survivors and Medical Professionals
All enquiries, book requests, medical article requests, membership fees, items for newsletters and donations to
The Secretary, Lincolnshire Post-Polio Network
PO Box 954, Lincoln, Lincolnshire, LN5 5ER United Kingdom
Telephone: +44 (0)1522 888601
Facsimile: +44 (0)870 1600840
Email: info@lincolnshirepostpolio.org.uk
Web Site: www.lincolnshirepostpolio.org.uk
The Lincolnshire Post-Polio Network takes great care in the transcription of all information that appears at this site. However, we do not accept liability for any damage resulting directly or otherwise from any errors introduced in the transcription. Neither do we accept liability for any damage resulting directly or otherwise from the information available at this site. The opinions expressed in the documents available at this site are those of the individual authors and do not necessarily constitute endorsement or approval by the Lincolnshire Post-Polio Network.
© Copyright The Lincolnshire Post-Polio Network
Copyright is retained by The Lincolnshire Post-Polio Network and/or original author(s). Permission is granted to print copies of individual articles for personal use provided they are printed in their entirety. Links from other Internet WWW sites are welcome and encouraged. We only ask that you let us know so that we can in future notify you of critical
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 9 of 10
changes. Reproduction and redistribution of any articles via any media, with the exception of the aforementioned, requires permission from The Lincolnshire Post-Polio Network and where applicable, the original author(s).
Document preparation: Chris Salter, Original Think-tank, Cornwall, United Kingdom.
Document Reference: <URL:http://www.zynet.co.uk/ott/polio/lincolnshire/library/usa/gi.html> Created: 7th February 1997
Last modification: 31st January 2010.
http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/usa/gi.html 12/02/2016, 12:31 Page 10 of 10
Gastrointestinal Involvement in the Post Polio Syndrome (PPS) Read More »
A Qualitative Survey of Postpolio Syndrome in the Leeds area.
S. A. Arshad, St. Mary’s Hospital, Greenhill Road, Leeds.
Lincolnshire Post-Polio Library copy by kind permission of Dr. Arshad. INTRODUCTION.
There were six major polio epidemics in the United Kingdom early this century. In the Leeds area, more than 400 cases of Polio were notified between the years 1940 – 1962 inclusive[1]. After the successful introduction of mass vaccinations with the Salk and then the Sabin vaccines in 1956 and 1961, new polio cases became extremely rare.
It is known that that many people with a history of polio may develop new symptoms after decades of stable functioning. The time lag varies but the usual period between the onset of these symptoms is about 30 years[2]. The risk of developing these symptoms appears to be correlated with the severity of the original paralysis[3].
Most common new health problems reported by Postpolio patients are fatigue, muscle pain, joint pain and weakness. Functional problems include walking, climbing stairs and dressing[4]. The suggestion is that these new symptoms should be labeled as the “Postpolio” syndrome.
Table1 Problems experienced by those who had polio many years ago.
weakness, pain or cramp in muscles
increasing arthritis
increasing arthritis secondary to unusual use of muscles and joints increasing fatigue
skin and circulatory problems secondary to autonomic nervous system involvement
osteoporotic changes leading to fractures increasing deformity e.g. scoliosis increased risk of deep venous thrombosis
increasing respiratory problems, including possibly undiagnosed sleep apnea increasing difficulty with mobility
increasing difficulty with work and activities of daily living difficulty in obtaining orthoses
difficulty in obtaining suitable wheelchairs
A qualitative study was carried out between the months of September and November 1998. Interviews were done on 14 patients suffering from the post-polio syndrome. They were between the ages of 40 and 72 years and eight males and six females. All of them had polio in childhood, before the age of 10 years
with various impairments.
The aim of this study was to explore possible influences on the perceived quality of life for people with PPS. This is a pilot case series in descriptive epidemilogy.
METHOD.
A structured interview schedule was used. The questions covered various aspects employment, appearance, social support etc.
The answers were analyzed with NUD.IST software[5] using cross-case comparisons [6] assessing the similarities and differences emerging as patterns between and within cases.
The interviews were conducted in the patients residences with spouses present in some cases. All questions were answered to the best of their abilities.
RESULTS.
The results of the structured interview was as follows:
1. occupation: 8 were working but had to modify their practices
4 had to give up work due to post polio syndrome
1 had retired
2. family relationships: 11 had supportive families and spouses*
2 lived alone and kept themselves in isolation
1 had problems with their families understanding their illness
3. activites in the house: 10 needed help from their spouses, family members or home help
3 managed their own household chores
1 was wheelchair bound but had the house fully adapted
4. negative feelings: 12 experienced anxiety or depression about their condition
2 were resigned to their condition (taking it as it comes)
5. sleeping pattern: 13 had disrupted sleep due to pain and exhaustion
1 no problem
6. personal hygiene: 10 needed help ranging from complete dependence to aids
3 managed independently with difficulty
1 was completely dependent
7. leisure/hobbies: 12 were restricted in amount of time or equipment
2 had to give up their hobbies
* Out of which only 2 reported a satisfactory physical sexual relationship, the rest had difficulties.
CONCLUSION.
It is apparent that these symptoms have significant potential consequences for the individuals experiencing postpolio sequelae in their functional capabilities to cope with activities to cope with activities of daily living (ADL). Obviously reports of fatigue, pain, muscle weakness and atrophy, respiratory difficulties have significant effects on mobility. Individuals experiencing PPS note difficulties in walking, using wheelchairs, transferring in and out of chairs, never mind negotiating stairs. As one might expect, mobility difficulties also potentially affects one’s ability to remain employed.
In terms of being self sufficient, individuals faced increasing difficulties in dressing, washing among the activities performed at home as well as sexual functioning. In fact respondents have been forced to alter their activities of daily living, expand their reliance upon mechanical aids and personal assistants. Generally PPS sufferers report having to “slow down” in terms of activities in a day to day basis.
Not surprisingly these changes have an important emotional impact. The anxiety, frustration, uncertainty and isolation must have a significant influence on one’s outlook and response to the demands of daily living, particularly in light of the likelihood of a more restricted lifestyle. A concrete manifestation of these changes is a decline in one’s capacity to maintain a social life.
There may be comorbid or secondary medical conditions contributing to development or aggravation of symptoms. Being a diagnosis of exclusion, there are no specific tests for the Postpolio syndrome[7]. It is therefore important to compare quality of life with other neurological conditions having a similar set of symptoms, to compare differences associated with disturbance of activities of daily living.
REFERENCES.
1. Medical Officer of Health Reports; Archives, Leeds Central Library.
2. Cashman NR, Neurological manifestations of the Postpolio syndrome. Curr Op Orthop 1992;3:224-
8.
3. Jubelt B, Cashman NR. Neurological manifestations of the postpolio syndrome. Critical Rev Neurol
1987;3:199-220. [PubMed Abstract]
4. Chetwynd J, Botting C, Hogan D. Postpolio syndrome in New Zealand: a survey of 700 polio
survivors. New Zealand Medical Journal Sept. 1997; 406-8.
5. Anon QSR. NUD.IST; 4th ed.; Melbourne, Australia. Qualitative Solutions & Research Pty Ltd 1997 Data Analysis.
6. Miles M, Huberman M. Qualitative Data Analylsis; an expanded sourcebook; 2nd ed., Thousand
Oaks, California. Sage Publications 1994.
7. Thorsteinsson G, Subspecialty Clinics: Management of Postpolio syndrome. Mayo Clin Proc 1997;
72: 627-638. [Lincolnshire Library Full Text]
The Lincolnshire Post-Polio Network
Registered Charity No. 1064177
An Information Service for Polio Survivors and Medical Professionals
All enquiries, book requests, medical article requests, membership fees, items for newsletters and donations to The Secretary, Lincolnshire Post-Polio Network PO Box 954, Lincoln, Lincolnshire, LN5 5ER United Kingdom Telephone: +44 (0)1522 888601 Facsimile: +44 (0)870 1600840 Email: info@lincolnshirepostpolio.org.uk Web Site: www.lincolnshirepostpolio.org.uk
The Lincolnshire Post-Polio Network takes great care in the transcription of all information that appears at this site. However, we do not accept liability for any damage resulting directly or otherwise from any errors introduced in the transcription. Neither do we accept liability for any damage resulting directly or otherwise from the information available at this site. The opinions expressed in the documents available at this site are those of the individual authors and do not necessarily constitute endorsement or approval by the Lincolnshire Post-Polio Network.
© Copyright The Lincolnshire Post-Polio Network 2000 – 2010.
Copyright is retained by The Lincolnshire Post-Polio Network and/or original author(s). Permission is granted to print copies of individual articles for personal use provided they are printed in their entirety. Links from other Internet WWW sites are welcome and encouraged. We only ask that you let us know so that we can in future notify you of critical changes. Reproduction and redistribution of any articles via any media, with the exception of the aforementioned, requires permission from The Lincolnshire Post-Polio Network and where applicable, the original author(s).
Document preparation: Chris Salter, Original Think-tank, Cornwall, United Kingdom.
Document Reference: <URL:http://www.zynet.co.uk/ott/polio/lincolnshire/library/uk/leedssurvey.html> Created: 13th May 2000
Last modification: 31st January 2010.
A Qualitative Survey of Postpolio Syndrome in the Leeds area Read More »
Post-Polio Syndrome: A Perspective from Three Countries
Gunnar Grimby, MD, PhD, FRCP (London) Section of Clinical Neuroscience and Rehabilitation, Sahlgrenska Academy at University of Gothenburg, Sweden Disclosure: nothing to disclose
Jianan Li, MD Nanjing Medical University, Nanjing, China Disclosure: nothing to disclose
Carol Vandenakker, MD University of Califomia/Davis Disclosure: nothing to disclose
Senior Editor:
CASE SCENARIO A 55-year-old woman with a history of polio at the age of 2 years presents with complaints of increasing fatigue and pain in her legs with moderate activity, including performing general household tasks and ambulating distances greater than a few city blocks. She reports that she had residual weakness in her legs that limited her participation in school athletics as a child and teenager, but no fatigue or pain. She has mild scoliosis but this is not accompanied by any symptoms and does not affect her activity or social participation. The symptoms of fatigue and pain began to emerge about 10 years ago and have steadily worsened to the point that she is having difficulty maintaining her previous level of function. Her parents told her that she did not require ventilatory support during the acute illness and never needed bracing during child hood. She describes her pain as primarily achy but sometimes more intense, sharp and radiating from the back. Rest usually helps to relieve pain and fatigue. She experiences the fatigue as both muscular and more generalized, gradually increasing with walking or other physical activity. These symptoms disturb her sleep intermittently during the week. She reports some mild depressive symptoms but does not believe that she suffers from depression. She is employed full-time as a paralegal, as she has been for many years. She used to be an avid golfer but has been unable to play the sport in recent years.
What additional evaluation, including history and physical examination, laboratory, or other studies, would you recommend for this patient? What do you think are the possible etiologies of her symptoms? How would you advise her concerning treatment of her condition including medications, lifestyle modifications, or exercise?
iser Permanente
Jianan Li, MD, Responds
Clinical Evaluation Muscle strength assessment, electromyographic (EMG) stud ies and motion analysis may provide objective evidence of PPS pathology and help identify functional prognosis [4]. Motion analysis for a patient with weakness or endurance issues may help identify the possible beneficial effects of rehabilitation interventions such as orthoses and assistive devices.
Over the last 20 years, post-polio syndrome (PPS) has be- come well-recognized as occurring in some patients with a history of polio. The case presented is a typical patient with PPS. China has the largest population of people infected by poliomyelitis in the world, but few PPS cases have been reported [1]. There may be several causes for the low inci dence of PPS in China [2]: most polio patients are living in the countryside and have poor access to qualified doctors with sufficient knowledge regarding PPS. Most Chinese doc tors have limited training in identification of PPS from a lack of PPS education in medical schools and postgraduate train ing [3]. PPS could be misdiagnosed as osteoarthritis, chronic pain syndrome (without a specific cause identified), depres sion, or deconditioning. Many Chinese polio patients are relatively young, so the contribution of aging to the disorder may not be evident yet.
Treatment The recommended treatment for this patient may include energy-saving strategies for daily living, low-intensity exer cise for maintenance of muscle efficiency and metabolism, as well as medications for pain, sleep disturbance, or depres sion. In addition, psychological treatment for depression might also be helpful.
PM&R 1934-1482/09/$36.00 Printed in U.S.A.
© 2009 by the American Academy of Physical Medicine and Rehabilitation
Vol. 1, 1035-1040, November 2009
DOI: 10.1016/j.pmrj. 2009.09.005
1035
1036
Grimby et al
POINT/COUNTERPOINT
Theoretically, traditional Chinese medicine is beneficial for adjustment of imbalanced neuromuscular function and psychological function through adjustment and balance of yin and yang (negative and positive energy). Some studies have demonstrated the effectiveness of acupuncture and Chi nese exercise on polio survivors. However, there are no published randomized controlled studies providing clear evidence of the effectiveness of these Eastern medicine treat ments for PPS. Cultural influences on clinical management, design of assistive devices, and environment modification as well as ergonomics in employment settings for PPS patients need to be considered in future studies.
Relevant Research Studies The following data might be important to demonstrate a potential strategy for prevention of PPS in 20 to 30 years. There was a nationwide outbreak of polio in China from 1989 to 1990 affecting the Pi and Shuyang counties in Jiangsu Province. A total of 1012 cases were identified [5]. A survey showed that 42% had one limb affected, 47% had 2 limbs affected, and 11% had 3 or more limbs affected. This was the last major outbreak of poliomyelitis in the world. After 15 years of comprehensive rehabilitation services (pro vided since 1993), a cohort of 648 people (350 males and 298 females, age 20 years on average) were followed in 2008. The interventions included the following. Surgery. Surgery on extremities was performed on 488 patients (830 operations); procedures included joint plastic ity procedures and tendon lengthening, transferring, and release. Spinal surgeries were performed in 98 cases and spinal revision surgery was required in 6 cases. Rehabilitation. Training for strength, joint motion, gait, and activities of daily living; preoperative and postoperative therapy; and psychological interventions were provided. The number of orthoses prescribed for lower limbs was 2756 braces for 455 patients; 153 pairs of corrective shoes were provided. Spinal braces were provided for 232 patients. A total of 2193 crutches and 296 wheelchairs were provided.
As a result of the 15-year program, significant improve ments in physical functioning have been demonstrated in all patients. The most important achievement is the recovery of ambulation capacity in 95.8% of patients. All patients with one-leg involvement achieved independent walking. A ma jority (90.9%) of the 296 patients with paraplegia and quad riplegia regained independent walking ability. Wheelchair dependence was seen in 27 patients with the most severe paralysis in 3 or 4 limbs in this group.
Dependence on orthoses for walking has been dramati
cally reduced over time. Among 455 patients with orthoses at entry into the study, 106 patients (23%) reduced their de pendence on orthoses. For example, 65 patients with bilat eral knee-ankle foot orthoses (KAFO) now only require a unilateral KAFO; 20 patients with a unilateral KAFO pro gressed to ankle foot orthoses (AFO); and 21 patients with an AFO progressed to walking without an orthosis. Of the cohort, 162 patients (36%) do not require an orthosis as they showed sufficient improvement in physical functioning; these included 71 patients with initial bilateral KAFOs, 70 patients with an initial unilateral KAFO, and 21 patients with an initial AFO. Only 187 (41%) are still requiring an orthosis, including 27 patients with bilateral KAFOs, 47 patients with a single KAFO, and 13 patients with an AFO. The authors conducted gait analysis for a selected group of 20 patients. The results indicated that 75% of patients who progressed from KAFO to AFO within 2 years significantly improved their gait and also reduced the oxygen cost of ambulation.
The question is whether the reduction in the use of ortho ses will contribute to an increase in the incidence of PPS in 20 to 30 years. To help answer the question, the authors have commenced a long-term follow-up study of those polio pa tients. EMG and gait analysis will be conducted with selected patients. In addition, a community-based rehabilitation pro gram has been organized for those patients. The authors postulate that well-designed activities and patient education will have the potential to reduce the incidence of PPS.
Further studies might be focused on the following ques tions: What is the pathology or etiology of PPS (ie, overuse or disuse of affected muscles, and how is it related to the degeneration of individual nerve terminals in the residual motor units)? Does biomechanical adaptation of affected limbs lead to a better alignment of lower limbs, resulting in better mechanical efficiency of muscles and lower oxygen consumption for walking and daily living activities? Is PPS predictable and preventable by careful monitoring of electro physiology, gait and motion analysis, and symptoms?
REFERENCES 1. Shen L-W, Wu J-), Jiang Y-P. Post-poliomyelitis syndrome: 3 case
reports. Chin J Clin Neurosci 2006;14:520-523. 2. Li J. Therapeutic exercise and rehabilitation for post-polio syndrome.
Chin J Rehabil Med 2000;15:185-186. 3. Zhu D, Li F. Post-polio syndrome. Chin J Orthopaed 1996;6:63-65. 4. Grimby G, Stalberg E, Sandberg A, Stibrant Sunnerhagen K. An 8-year
longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio. Muscle Nerve 1998;21:
1428-1437. 5. Xu G, Li J, Shao Q. Analysis of poliomyelitis in Pi County. Chin J Clin
Rehabil 2005;19:238-242.
Gunnar Grimby, MD, PhD, FRCP (London), Responds
The patient represents a typical case of post-polio syndrome (PPS), probably from successive loss of muscle mass during later years. The patient also seems to overexert herself. There
are no reasons to assume respiratory limitations are causing the reduced physical activity and would suggest the follow ing further evaluations.
PM&R
Vol. 1, Iss. 11, 2009
1037
Clinical Evaluation Exercise tolerance should be further analyzed with respect to type and amount of activities, habits of pauses and resting, and occurrence of pain and fatigue. The distribution of pain should be described using pain drawings [1]. Other reasons for pain and fatigue not directly related to late effects of polio should be considered and assessed using clinical examination and laboratory tests. Subjective experience of new muscle weakness and fatigue should be recorded with respect to specific muscle groups. For weak muscles, manual muscle tests could be performed but would not be relevant for 4-grade strength or higher. Entrapment syndromes should be excluded. Gait should be analyzed by clinical observation.
Muscle strength can be measured using stationary meth ods (isometric and/or isokinetic) or with handheld dyna mometers for relevant muscle groups, such as quadriceps, hamstrings, dorsiflexors, plantarflexors, biceps, and triceps, and grip. Comparison should be made between sides and with reference values. To establish which muscle groups have been affected by polio, electromyography can be used. If possible, an estimate of motor unit size is recommended, preferably with macro-electromyography [2,3]. This will also provide information on the denervation/reinnervation pro cesses within a motor unit. The presence of very large motor units is a risk factor for further deterioration in muscle function. Even if respiratory function is not assumed to limit performance, vital capacity should be measured for baseline documentation. Exercise tolerance may be further analyzed using a bicycle ergometer. Even if maximal heart rate cannot be approached because of muscle weakness, the anaerobic threshold may be defined. Electrocardiogram and blood pressure should be recorded during the evaluation.
find strategies for reducing fatigue and pain as well as devel oping individualized energy-saving strategies. Clinical and research experience has shown that pool exercise may reduce pain and improve performance and it can be generally rec ommended in this case [4]. For muscle groups with moder ately reduced muscle strength, a submaximal resistance training program can be used with close monitoring of mus cle strength changes to avoid overuse weakness [3]. If gait analysis and assessments of muscle function indicate that the use of a cane may be appropriate, the patient should be encouraged to try using one. However, it may not be accepted immediately. The need for other assistive technologies or home modifications should also be considered.
It is important for the physician to provide information on PPS and to discuss the etiology and prognosis of the disorder with the patient and family members. Finally, it is worth mentioning that treatment with intravenous immunoglobu lin has given some promising results in Swedish studies for improving function and health-related quality of life [5] and may be considered in this case if available.
The patient should be seen by a physiatrist or other physician with competence in treating patients with late effects of polio when the results of testing are available, followed by rechecks at 3 or 6 months. A multiprofessional assessment and follow-up with a rehabilitation team is im portant. Further appointments can then be discussed.
REFERENCES
with late effects of polio. Arch Phys Med Rehabil 1998;79:915-919. 2. Grimby G, Stålberg E, Sandberg A, Sunnerhagen K. An eight year
longitudinal study of muscle strength, muscle fiber size and dynamic electromyogram in individuals with late polio. Muscle Nerve 1998;21:
1428-1437. 3. Grimby G, Stålberg E. Dynamic changes in muscle structure and elec
trophysiology in late effects of polio with aspects on muscular trainabil
ity. Scand J Rehabil Med 1994;Suppl 30:33-44. 4. Willén C, Sunnerhagen KS, Grimby G. Dynamic water exercise in
individuals with late poliomyelitis. Arch Phys Med Rehabil 2001;82:66
Borg K. Intravenous immunoglobulin for post-polio syndrome. A ran domized controlled trial. Lancet Neurol 2006;5:493-500.
Treatment
Carol Vandenakker, MD, Responds
diagnoses in the differential should include: neurogenic clau dication caused by spinal stenosis; polyradiculopathy; osteo arthritis in one or more of the large lower extremity joints; vascular claudication, and depression. Here are some key areas of evaluation.
This case is typical of a patient presenting to a post-polio clinic, often self-diagnosed as post-polio syndrome (PPS). The diagnosis of PPS is based on criteria established by a March of Dimes consensus statement. These criteria are: prior episode of acute polio; a period of neurologic recovery, followed by at least 15 years of functional stability; onset of new weakness or muscle fatigability, with or without gener alized fatigue, muscle atrophy, or pain; and exclusion of other medical, orthopedic, or neurologic conditions [1]. Al though complaints of pain and fatigue are 2 of the primary symptoms of PPS, the syndrome is a diagnosis of exclusion and other potential etiologies must be considered. Other
Clinical Evaluation
Assessing the likelihood of other conditions in the differential is essential. The exact location of pain is important. Is the pain primarily in muscles or around joints? Does it seem to radiate from the back? Does the pain represent a radicular or
1038
Grimby et al
POINT/COUNTERPOINT
cular system. Chronic muscle pain with increased weakness, especially in a limb-girdle distribution or with a temporal relationship to statin use, may prompt measurement of cre atine phosphokinase and liver function levels. A patient with fatigue should have a complete blood count, blood chemis try, and thyroid panels to screen for anemia and endocrinel metabolic disease.
referral pattern? Is the pain in normal muscles; functionally intact, polio-affected muscles; or muscles that are severely atrophic? Further information is also needed on the aggravat ing and alleviating factors. Does the pain present during activity or later in the day? Do pain and fatigue occur simul taneously? Do symptoms progress as she continues certain activities? Can she alleviate symptoms by simply standing still, leaning forward, or sitting down? Do symptoms persist for several days after the activity? When the pain and fatigue disturb her sleep, does she have difficulty falling asleep or frequent awakening during the night? Is pain at night related to position? Are the episodes of sleep disturbance associated with muscle cramping and twitching? Is there any relation ship between the amount of activity she has done during the day and the episodes of sleep disturbance? Is her generalized fatigue related to activity or quality of sleep? Does she wake up refreshed or tired? Medical history, current medications, family and social history, and a complete review of systems may also add pertinent information. Our patient reports some mild depressive symptoms. Further questioning or screening with a depression inventory will narrow the differ ential diagnosis.
The importance of the physical examination should not be underestimated in evaluating a polio survivor. Unlike many other neuromuscular diseases, the residual effects of polio are variable in each individual, and careful assessment is key to understanding body mechanics and function, Assessment of vital signs, heart, and lungs will indicate general wellness and cardiovascular fitness level. Specific spine examination, eval uating scoliosis, screening for lumbar radiculopathy, and special maneuvers may identify spine pathology. Evaluation of the extremities must include joint function and provoca tive maneuvers. Although limbs severely affected by polio may have discoloration and decreased temperature, periph eral pulses and skin sensation should be intact in the absence of peripheral vascular disease or neuropathy. A careful and complete manual muscle examination of all major muscle groups will provide insight into the patient’s unique body mechanics and areas at risk from agonist-antagonist muscle imbalances or increased/abnormal stress with weightbearing or movement. Clinical gait evaluation is an excellent tool to further understand biomechanics of functional mobility and compensations.
Additional laboratory or radiographic studies might be indicated based on information and findings obtained from the history and physical exam. There are no specific diagnos tic studies for PPS, but studies may confirm other etiologies or conditions contributing to symptoms. Electrodiagnostic studies are not necessary for the diagnosis of PPS but may provide evidence of the effects of polio in cases that do not have a clear clinical history [2]. They can be used to screen for nerve entrapments or lumbar radiculopathy. Radiologic studies can reveal the degree of lumbar scoliosis and the extent of degeneration in the spine or other lower extremity joints. If neurogenic claudication remains in the differential, magnetic resonance imaging of the spine is indicated. Arterial Doppler studies and segmental pressures can assess the vas
Treatment In this case, the symptoms of leg pain and fatigue are most likely polio-related and probably from PPS. The patient meets the criteria of previous polio, functional stability, and new muscle fatigability. Pain as reported by this patient is commonly associated with PPS, but not essential to meet the diagnostic criteria. If the pain is not simply overuse muscle pain, but from a musculoskeletal problem, the diagnosis of PPS should be delayed. If appropriate treatment of the mus culoskeletal problem does not abate muscle fatigue, the di agnosis of PPS can be made.
The pathophysiology and treatment of PPS have not been clearly defined and proven. The peripheral disintegration model proposed by Weichers and Hubbell [3] describing gradual loss of axon sprouts has become the accepted expla nation for weakening and fatigability of polio-affected mus cles. The secondary symptoms of generalized fatigue and pain are less clearly defined with multiple potential etiolo gies. Initially, the symptoms of increased weakness and fa tigue were attributed to overuse. Although many related musculoskeletal conditions are related to overuse or progres sive degenerative changes, exercise or an active lifestyle has not been directly linked to increased loss of axon sprouts or development of PPS. Adaptations in functional activities, lifestyle modifications, and a controlled exercise program have proven to be beneficial in most cases [4). As polio survivors have become aware of PPS, many have decreased activity to the point that deconditioning and disuse atrophy are common.
Whether a patient meets the exact criteria for PPS may not be important. Treatment of PPS is based on symptoms not pathophysiology. To date, the authors do not have a medica tion to stop the loss of axon sprouts or to slow the decrease in numbers of motor units with aging. Without a cure, inter ventions are based on management principles that may apply to all polio survivors with residual paralysis, not just those with PPS. Musculoskeletal problems and loss of biomechani cal efficiency related to muscle imbalance, joint deformities, and asymmetric forces on joints, ligaments, and connective tissue are common. Pain may result from arthropathy, bursi tis, tendonitis, peripheral nerve entrapments, radiculopathy, osteoporosis, and other conditions. These medical condi tions are related to the sequelae of polio, but do not meet the criteria for diagnosis of PPS. They would be referred to as “other orthopedic conditions.” Although these musculoskel etal problems are not unique to polio survivors, they often go unrecognized by health professionals unfamiliar with se quelae of polio. Failure to recognize limitations of partially denervated muscles may result in inappropriate treatment.
PM&R
Vol. 1, Iss. 11, 2009
1039
process the information and deal with the psychological issues associated with new or recurrent disability before accepting any intervention. A psychologist or local support group is often helpful during the process of acceptance. Long-term decisions regarding employment and recreation are best addressed later in the treatment course after the basic recommendations have been implemented.
Inexperienced health providers may be well-served by refer ring PPS patients to a post-polio specialist.
Recommendations for treatment must be individualized based on a detailed assessment by an experienced clinician. Ideally, pain can be controlled through avoidance of overuse and adaptations to decrease stress on weak muscles and unstable or degenerative joints. The adaptations may include therapies to optimize muscle balance or joint alignment, orthoses, or assistive devices. Pain medications should be used for a specific functional benefit, not to mask the signs of overuse. Fatigue can be managed with pacing of activities and regular rest periods. Sleep hygiene should be addressed and optimized. Regular mild to moderate exercise should incor porate stretching, gentle strengthening of muscles grade 3 or higher, and cardiovascular conditioning [5,6]. The patient must recognize signs of muscle overuse (cramping, twitch ing, crawling sensation, or pain) and learn to adjust exercise and activity accordingly.
A self-educated polio survivor may be ready to accept recommendations immediately, whereas others will need to
REFERENCES 1. Post-Polio Task Force. Post-polio syndrome update. Biosci Rep 1997;5. 2. Cashman NR, Maselli R, Wollman RI, Ross R, Simon R, Antel JP. Late
denervation in patients with antecedent paralytic poliomyelitis. N Engl
J Med 1987;317:7-12. 3. Wiechers DO, Hubbell SL. Late changes in the motor unit after acute
poliomyelitis. Muscle Nerve 1981;4:524-528. Peach, PE, Olejnik S. Post-polio sequelae: Effect of treatment and non compliance on post-polio sequelae. Orthopedics 1991;14:1199-1203. Gawne AC, Halstead LS, Post-polio syndrome: Pathophysiology and
clinical management. Crit Rev Phys Rehabil Med 1995;7:147-188. 6. Einarsson G. Muscle conditioning in late poliomyelitis. Arch Phys Med
Rehabil 1991;72:11-14.
World Polio Day on October 24 is a reminder that great strides have been made in eradicating poliomyelitis through vaccination (Salk, 1955; Sabin, 1962 [1]). The Global Polio Eradication Initiative launched in 1988 has certainly led to the sparing of millions of children and adults from death and disability. In 2008, there were 1652 confirmed cases of paralytic polio reported worldwide. At this time, 4 coun tries—Afghanistan, India, Nigeria, and Pakistan-are en demic for polio. The World Health Organization estimates there are 20 million people worldwide with disability from poliomyelitis [2]. According to surveys by the National Cen ter for Health Statistics, there were about one million polio survivors in the United States in the 1990s, a subpopulation primarily of “baby boomers’ who contracted the disease in the 1940s and 1950s [3].
In this discussion, a distinction is made between late effects of polio (mainly musculoskeletal) and the subcategory post-polio syndrome (PPS), a neurologic disorder. The prev alence of PPS is reported to range from 28% to 64%, and the manifestations of PPS are reported to be similar around the world [4]. The functional course, risk factors, and prognosis for PPS are unclear [5]. Fatigue is the most prominent symptom and may be due to central or peripheral causes. Patients report symptoms of both fatiguing muscles and generalized fatigue. The importance of evaluating neuromuscular effects on respira tory function must be emphasized, especially as these effects may be a contributor to fatigue through hypoventilation [6].
There are differing emphases in these commentaries with no major disagreements, and certainly a physiatric approach is used by each of the discussants. The evaluation of the patient with late effects of polio, including PPS, especially those in mid- to late-life, may be very difficult. PPS is indeed
a diagnosis of exclusion as there is no biomarker for the disorder. Other diagnoses may emerge as the patient ages.
Dr. Li discusses the situation in China where the popula tion may be less (or not yet) affected by PPS or perhaps not identified because of various factors. The opportunity cer tainly exists in China to study the progression in a recently infected cohort and readers must await further studies from that country. Dr. Grimby emphasizes a specific workup for neuromuscular aspects, including electrodiagnostic studies to confirm the effects of the polio virus and for identification of what muscles are subclinically involved. Dr. Li also refers to the benefits of evaluations such as electromyography and motion analysis. Dr. Vandenakker focuses her discussion on the differential diagnosis using electrodiagnostic, laboratory, and radiographic studies in some cases to make sure that no other musculoskeletal, neurologic, or metabolic/endocrino logic disorder is missed.
Pain management and rehabilitation are based on specific symptom-based assessments and an understanding of the patient’s level of activity and participation. Individualized prescription may include therapeutic exercise and lifestyle modifications, weight reduction programs, energy conserva tion, strengthening programs, adaptive devices, bracing, mo bility aids, and ventilatory support, but treatment plans will vary widely. The clinician must be aware that 3 factors may contribute to PPS: aging, overuse, and disuse; the contribu tions of each will vary in an individual patient and are difficult to distinguish. In addition, the limitations of the manual muscle test are clear in this disorder because of the fatigability of muscles that have no apparent loss of strength.
Intravenous immunoglobulin is not approved by the United States Food and Drug Administration for this disor
1040
Grimby et al
POINT/COUNTERPOINT
der. Use of intravenous immunoglobulin is more common in Scandinavian countries, where most of the research has been conducted. The cost may be prohibitive for widespread use. Other pharmacological interventions, acupuncture, or other alternative medicine approaches have not been proven to be effective. Readers must await additional studies on the biol ogy of PPS, which remains poorly understood.
The case represents what physiatrists do best when patho physiology is unclear and medical cure is elusive, yet treatment is not. Physiatrists integrate a comprehensive history of the condition, including associated symptoms, with a thorough physical examination, supplemented with diagnostic studies to employ a variety of strategies, with therapists and other provid ers, to reduce disability using an individualized approach. This patient, with the right rehabilitation treatment plan, may stay working and even get back to the golf course.
REFERENCES 1. Oshinski DM. Polio: An American Story. New York, NY: Oxford Univer
sity Press, 2005. 2. World Health Organization. Poliomyelitis fact sheet. Available at: www.
who.int/mediacentre/factsheets/fs114/en/index.html. Accessed Octo
ber 2, 2009 3. Post-Polio Health International. Be credible, check your facts. Available
at: www.post-polio.org/Were Here BeCred.html. Accessed October 2,
drome. JAMA 2000:384:412-414. 5. Stolwijk-Swuste JM, Beelen A, Lankhorst GJ, Nollet F; CARPA Study
Group. The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: A systematic review. Arch Phys Med Rehabil 2005;86:1693-1701. Dahan V, Kimoff J, Petrof BJ, Benedetti A, Diorio D, Trojan DA. Sleep disordered breathing in fatigued postpoliomyelitis clinic patients. Arch Phys Med Rehabil 2006;87:1352-1356.
Post-Polio Syndrome A Perspective from Three Countries Read More »
Journal of the Peripheral Nervous System 12:56 (2007)
LETTER TO THE EDITOR
Polio and ageing: comment on article by Sorenson et al.
Dear Editor,
Tan concerned that in the article “Electrophysio logical findings in a cohort of old polio survivors” (Sorenson et al., 2006), the authors seem to have inaccurately cited a study (Doherty et al., 2003) and argued that the rate of motor unit loss in a cohort of polio survivors, which they found to be 2.9% annually over 15 years, is equal to normal ageing. They describe the Doherty et al. (2003) results as “a decline in the thenar MUNE counts from a mean of 288 to 139 between the ages of 40 and 60 years. This represents approximately a 50% decline, or 2-3% per year”
Sorenson et al., 2006, p 244).
The Doherty et al. (2003) reference for this quota tion is a supplement to the Joumal of Clinical Neuro physiology, which is not referenced on Medline, is not published online and is unobtainable in the UK through the British Library or medical libraries. How ever, the article refers back to Doherty and Brown (1993). In the 1993 study, the subjects with a mean thenar MUNE of 288 were 20-40 years, and the older group with a mean count of 139 were 63-81 years. Doherty and Brown (1993, p 364) make clear that their subjects are not between 40 and 60, writing that “On average, subjects in their seventh and eighth dec ades of life had about 50% fewer thenar MUS then younger subjects between 20 and 40 years of age.”
in the Doherty and Brown study, the mean age of the younger group is 30, and the mean age of the older group is 72. The age gap is 42 years. Sorenson et al. used an erroneous age gap of 20 years (40-60 years), selecting the upper and lower end of the age groups. This was divided into the percentage lost (51.7%), obtaining a 2-3% loss per year, which was similar to the polio loss of 2.9% per year. Using the gap of 42 years, the loss per year is 1.2% per year. A loss of 1.2% is similar to that found in other studies, such as Galea (1996), who found very little increase in the rate of loss until after age 70 when it rose to
1.9%. To lessen the effect of ageing, examining the first 5 years of the polio study, the rate of thenar loss is actually higher at 3.7% per year.
Separately examining the symptomatic postpolio group (82% of the sample) in the Sorenson etal study and continuing to use their method of calculation, the mean composite MUNE loss was 60.9% in 15 years 14.1% per year. The loss in the asymptomatic group was 22.2% 11.5% per year). Because of the small sample, this difference was not statistically significant but nevertheless, the symptomatic group lost nearly three times the number of motor units as the asymp tomatic group, whose loss was similar to ageing, i.e., 1.2% per year. This suggests that there may indeed be accelerated motor unit loss in polio survivors who develop new weakness and other symptoms.
This long-term study from the Mayo Clinic has had a significant effect on postpolio patients and their treatment, especially in the UK, and it is important that the Sorenson et al. result of 2.9% per year MUNE loss and its relationship to other studies of
age-related motor unit loss is clarified.
Sincerely, Dr. Ruth Bridgens School of Social Sciences
Cardiff University, UK
References Doherty TJ. Stashuk DW, Brown WF (2003). MUNE measure
ment of age related changes. Clin Neurophysiol 55:158-103. Doherty TJ, Brown WF (1993). The estimated numbers and
relative sizes of thenar motor units as selected by multiple point stimulation in young and older aduis. Muscle Nerve
16:355-366. Galea V (1996). Changes in motor unit estimates with ageing.
J Clin Neurophysiol 13:253-260. Sorenson EJ, Daube JR. Windebank AJ (2006). Electrophysio
logical findings in a cohort of old polio survivors. 1 Peripher Nerv Syst 11:241-246.
Address CONespondence o Dr. Ruth Bridgens 66 foran St Washitield, Chippenham, Wiltshire SN14 SLP, UK
2007 Peripheral Nerve Society
56
Blackwell Publishing
Polio and Ageing Comment on article by Sorenson et al Read More »
SA
10C
A 15-year follow-up of | Abstract–A population-based cohort of poliomyelitis survivors was estab
lished and followed for 15 years (mean time since polion yelitis was 10 yoni’s). neuromuscular over time, the cohen
Over time, the chont demonstrated only a modest decline in function as muca function in patients sured by strength measurements, electrophysiologic assessments, and timed functional tasks. There was no Association between symptoms of late deterio with prior
ration and magnitude of decline. Rather the presence of these symptoms was poliomyelitis associated with the magnitude of the residual deficits
INELROLOGY 2007 01:1070-1072
W
Eric J. Sorenson, MD; Jasper R. Daube, MD; and Anthony J. Windebank. MD
Progressive neurologie deficits in patients with a re mote history of poliomyelitis have been reported for many years. Despite these reports the natural his. tory of old polio remains unknown. In 1987, we be gan a population-based cohort study of 50 subiects with a remote history of paralytic poliomyelitis. We have bow extended the follow-up period on this co hort to 15 years. Specifically we addressed 1) the stability of strength in this cohort. 2; whether symp toms of progressive weakness are associated with the magnitude of decine with time, and 31 whether symptoms of progressive weakness are associated with the magnitude of baseline residual deficits.
age at the time of the acute poliomyelitis was B range 1.5 to 36). There were 22 women and 16 men.
The cohort demonstrated a modest decline in function Over the 15-year follow-up period. There pas à modest change in the NDS stores mean of 16 at baseline 21 at study termination p 0.01). Additionally there was a drop in sumated compound muscle action potentials (CHAP and sumated motor unit number estimations MUNES! vital capacity on pulmonary function testing, and all the timed functional tasks. The data from these measurements are summarized in table 2.
Quantitative isometrie sirength testing supported this decline in strength in the upper extremities, virtually all muscle groups declined significantly over time in the Torrer extremities. a similar decline in function occurred with time however, the changes of the measures were not
Methods. The demographies of the study population have been previousIV described. Fir yepresentare subjects were chosen from 208 patients who previous it had well-oumented paralytic poliomyelitis living in Olmsted County at the time of the intee fion. Each subject completed a selias ministered Questionnaire validated in the previously publishe studies
Lach subjent tras assessed by the following ontcome measures manual muscle testing via the Neurologie Disability Scale (NDSE score table 11 quantitative isometric strength testing see table 11. electrophysiologic testing for compound muscle action potential amplitudes bilateral median and peroneal nervent and motor unit number estimates ibilateral mechan and peronea’ nentes) and a battery of tined functional tanks time to walk 100 ft. Standard ized pegboard tests of placement and displacement, pin and collar manipulation, and see manipulation All eruinations were completed in the same mama’at all time points single occur
tional therapist complete all the timed funtional tasks at barn bine and and 10-rear time points. All examiners were bonded to the subject other measurit scores and imptom status
ysis of variable for repeated leasures was compleie for the baseline juveat, and 1- ea folosip data. Iluxon lank-san TAGS BETA completed to letermine whether there was an associa tion between the subjects symptom status and the magnitude of decline or the magnitude oi baseline deficits
Twenty-five of the 35 subjects had progressive weak ness at the beginning of the study in 1957. The magnitudo of change over the 15-year follow-up period was compared beticon those symptomatic at baseline and those asvu. tomatic at baseline. There were no significant differences identified in any of the outcome measures between theme two groups. There was a mean decline in NDS scores of 3 pointa for the symptomatic group and a moun decline of 4 points for the asymptomatic group (p = 0.02) (figurei Elec tropluysiolour testing demonstrated a mean decline in the summatel CMAP of 5.9 V m the symptomatic group and ai 89 mv decline in the asymptomatic group = 0.591 Sunmated MUNES demonstrated a mean decline of 139 motor units in the symptomatic group compared with 154 motor units in the asymptomatic group (D = 0.90). Thore were no differences identified in any of the timed function taskrs, pulmonary function tests nor the quantitative iso metrie strength testing.
We compared baseline characteristics for all ujets who ever had symptoms of progressive weakness with those who remained suinptom free for the duration of the study. The magnitude of the baseline deficits was associa ated with having late symptomatie progression. The larger the deficit the more likely the subject was symptomatic. The mean baseline NDS score for the synptomatic group WAS 20 points compared with points for the symptom atic group (p = 0.04; see figure). Electrophysiology testing demonstrated a mean summated CMAP of 24.8 mV for the symptomatie grond at baseline compared with 318 oy in the asymptomatic group ( 0.09). The mean summated MINE W9 376 motor units in the symptomatic group at baseline compared with 5-10 motor units in the asympton –
Results. Of the original 50 subjects of the cohort, three subjects died during the 15-year follow-up period Nine of the remaining 17 refused further participation. Thirty eight of the original 50 completed the 15-year follow-up. The mean age of the 38 participants was 53 years range 36 to 711 in 1987 at the inception of the cobort. The mean
frein the lopart of Neurolou Mayo Clinic Rochester AN
Received June 10, 2004. Accepled in final forn Nosomber 29, 2004.
dehuss correspondance and re q uest. Eri Sorsun. In Ci 200 First Street St. Rochosier. I 53905.
1070) Spich o b AAN Eatine
Muscles included in Neurologica Disabbty Scale score
Muncte croups included in quantitative strength testing
Facial innovated muscles
Fibow lesiuni Elba extension Forearm pronation FOTCDD semanation Hand grip
Neck oxtousers Neck lexote Supraspinnis Infraspinatus
Knee extension Ankle dorsiflexion
Bruchiondale Wrist ferien Wrist extension
Asymptomatic Group Symptomatic Group
n=25
Finger extension
Thenar
Abdomina lliopsons Quadriceps femoris External and internal hamstring
Pereneus longus Este or digitorum longus Flexor chetorum longus Posterior tibialis Gastrocnemius
atic group = 0.04 The niean time to walk 100 ft was 33.7 seconds in the symptomatic group at buseline com pared with 26.2 seconds for the asyimptomatic group — 0.03). No significant differences were identified in other timed tasks or with the quantitative isometric strength testing
w
wwwwww
Asymptomatic Group
Symptomatic Group
n=31
Figure. The inpper graph represents the quantite plot of the change in the Neurological Disability Scale (NDS) score Op symptom starts at baselne (p = 0.62 The Core? graph represents the quantile plot of the baseline VDS score by symptom stains throughout the follow–up period ip 0.04). These graphs demonstrate that 120 association is identified between the presence of symptoms and the mag.
tude of change with time, however there is an USSOLE tion behcen the presence of symptoms and the magnitude of depict at the beginning of the study period.
Discussion. The syndrome of progressive weak ness late after paralytic poliomvelitis was quite com mon in our cohort. Thirty-one of the 38 subjects whom ive followed for 15 years reported symptoms of progressive weakness during the study period. Only seven subjects remained asymptomatie. The long follow-up period in our population-based cohort has allowed a unique and more accurate assessment of the long-term stability of neuromuscular function in these subjects. Our cohort, as a whole, did demon strate a modest decline in strength and functional performance with time,
The greatest risk factor for the presence or ab. sence of progressive symptoms was the magnitude of neurologic deficit at baseline. In nearls all our mea.. surements there was an association between symp tomatic progression and the magnitude of deficit at baseline. The larger the residual deficits present at baseline, the more likely the subjects were to be symptomatic. The rate of change over time, however, failed to demonstrate an association with the pres ence or absence of symptoms at baseline.
Our electrophysiology results agree with the find ings of Mccomas et al in which a loss of motor units was identified over time in a small group of
subjects with polio folloved for a short period of time Additionally, our findings are consistent with those of a recent study in which a 6-vear follow-up period failed to identify any deterioration and the subjects’ perceived health status was only associated with the magnitude of their residual deficit.
How the changes identified in our polio cohort compare with those of a normal aging population remains unknown. We did not include a normal con trol group at the inception of the cohort. In the ab sence of a nomal control population, the effects of normal aging in this cohort cannot be commented on. The other principal limitation of this study was the
March (
2 2) 2001 NEUROLOHIY 64 1071
Table 2 Means for all measured
bless otertime for the colort i
= 387
Bascline mean SD
car follow-up mcan
D:
15 pour follow-up means
21175
Neurological Disability Scale score Sumated camnud inusule action
potential amplitudes, my Motor unit number estimates Pulmonary vital capacity: Le Timed 100-ft walks
3.97 0.19
348 017 173 1139
352 35 157130 173 (32
263523
0.0001
1515
Object displeeing, s Pins and collars, Screw manipulation, s Right hear flexion, keren Loft clbow flexion ko-em Right elbow extension, k-em Left how extension, ke-em Right supination. hg-em Lett supination, ka-em Right np. kg-con Left grip, kg-om Right pronation kg-con Teit pronation, kenem
Right heeflexion, it-b Left knee flexion, it-13 Fight kann extension, it-ib Loft knee extension, ft-lb
Faight foot dor: ttlexion, ft-ita Left foot dorsiflexion, it-lb Right that plantartlexion 11-16 Lett foot plantarilexion, ft-lb
2663
0.29
3715 5718
16 15:
0.08
327
loss to follow-up of nine (19 ) of the subiectsIt is not unexpected with such a long follow-up time to lose a small number as we did. There was no appar ent difference between the nine subjects who with drew consent and the remaining cohort. Nonetheless, the dropout rate, while acceptable is not ideal for this study design,
Windbank A. Lit .). Danbek Kurland IT Codd MB Iverson Late effects of priv
titi in un con intensitet Nettbey 1991:11 -07 Portbank 1 Litebay ,
D e JR. Ihr . Lock ni profesion of alticile 11 sur ES patalte pieliem – ES
Duck Pi Kat: M. Lahman A l The Rochrator diabetic neurop
und design ele2 for ipes of neuropathy selecion based reprelucibilitoi neuropathie rests etalom 1961417807 Daube JR Estinating the ambientut this in it mustle Chin Neurophysiol 1995 12680 591.
References
7 Noliet . Den Trick . Lankhetst V
ad physie} functioning in pastpumzitis
V dra
Perceiver health
i n
its or farm fusta
nireplikere sclerosis. Wave Cha Pr 1972
A 15 year follow up of neuromuscular function in patients with prior poliomyelitis Read More »
August 28, 2006
Electrophysiological findings in a cohort of old polio survivors. [Part I – The Article]
Sorenson EJ, Daube JR, Windebank AJ.
Department of Neurology, Mayo Clinic, Rochester, MN, USA.
J Peripher Nerv Syst. 2006 Sep;11(3):241-6.
A population-based cohort of poliomyelitis survivors was established and followed for 15 years (mean time since polio was 40 years). Over time, the cohort demonstrated a modest decline in summated compound muscle action potential amplitudes (CMAP) and a moderate decline in the summated motor unit number estimates (MUNE). There was no association between symptoms of late deterioration and magnitude of decline. Rather, the presence of these symptoms was associated with the magnitude of the residual deficits. Two patterns of neuron loss were modeled (linear and proportional decline). The summated MUNE was a more sensitive measure of loss of motor units than was the summated CMAP and appears to be a more valid measure of attritional loss of anterior horn cells. Of these two models of neuron loss, the proportional loss of motor neurons was a better fit of the data than a linear loss.
[Links below open in new windows]
Link to Abstract at journal site. Full text requires a subscription to journal or one-off payment of US$39 (at the time of writing).
Link to US National Library of Medicine (NLM) PubMed entry PMID: 16930286.
https://www.ncbi.nlm.nih.gov/pubmed/16930286?dopt=AbstractPlus
+++
August 28, 2006
Survivors of childhood polio do well decades later as they age. [Part II – The Press Release]
ROCHESTER, Minn. — Mayo Clinic researchers have found that years after experiencing childhood polio, most survivors do not experience declines greater than expected in their elderly counterparts, but rather experience only modest increased weakness which may be commensurate with normal aging.
“Other researchers have suggested that polio is a more aggressive condition later in life, but we’ve actually found it to be relatively benign,” says Eric Sorenson, M.D., Mayo Clinic neurologist and lead study researcher. “Our results suggest that polio survivors may not age any differently than those in the normal population — they’re not doing too badly compared to their peers. This tells us that the cause for the decline in muscle strength in polio survivors may be aging alone.”
Polio is a contagious, viral illness that peaked in the United States in 1952, when 3,000 people died of the disease. Mass immunizations in the mid-1950s began to slow the spread of the disease, and the last case of polio not caused by a vaccine occurred in the United States in 1979. The three major types of polio include spinal polio, a paralytic polio that attacks nerve cells in the spinal cord; bulbar polio, in which the virus attacks motor neurons in the brainstem; and bulbospinal polio, a combination of spinal and bulbar polios. The effects of polio run the gamut from a complete return to normal function to paralysis of limbs to acute death. Following the illness, most patients are worried about their long-term prognoses, according to Dr. Sorenson.
To conduct this study, the researchers randomly selected a group of 50 polio survivors from the general population of Olmsted County, home of Mayo Clinic, and followed them for 15 years. The average age of participants at the study’s start was 53, and the patients were an average of 40 years past their childhood experience with polio. The researchers measured strength and loss of neurons at the beginning of this period, and then again five and 15 years later with electrophysiological testing, strength testing and timed tests of performing basic functions. They found modest declines. Each patient also completed questionnaires about symptoms of progressive weakness at the beginning and end of the study period. Though the majority complained of progressive weakness during the time they were studied, these symptoms did not correspond with their actual magnitudes of decline over time. Rather, the researchers found patients’ symptoms experienced were associated with the degree of residual weakness immediately following their polio infections.
“Overall, we found that strength changed very little in these polio survivors as they grew older, and we discovered the neurons dropped off at a rate comparable to other non-polio survivors as they aged,” says Dr. Sorenson. “We concluded this was normal aging on top of their old deficits. Very few had to change their homes or add adaptive equipment. Those who had weakness problems during our study had a larger deficit at the end of their childhood disease, making them more likely to develop symptoms. So, as deficits at the end of the disease increase, the probability of experiencing post-polio symptoms increases.”
The discrepancy between what some of the patients experienced with growing weakness and their actual measurements of strength and neuronal loss likely is due to increased sensitivity due to their disease experiences, according to Dr. Sorenson.
“Patients feel their weakness progressing, but when you measure it, it’s very modest,” he says. “Likely, they lost so much strength at the time of their illness that any change is very noticeable to them. Though the likelihood is high that patients who have had childhood polio will complain of weakness later in life, they can expect years of stability without the need for major lifestyle modifications.”
Other Mayo Clinic researchers involved in this study include Anthony Windebank, M.D., and Jasper Daube, M.D. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories.
Contact: Lisa Lucier
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
———
EurekAlert | Survivors of childhood polio do well decades later as they age. [Part II – The Press Release]
Public release date: 21-Aug-2006.
The original of the above article can be found at [link opens in new window]
http://www.eurekalert.org/pub_releases/2006-08/mc-soc081506.php.
+++
August 28, 2006
‘No Polio effects’ in later life / Many Polio Survivors Faring Well. [Part III – The Media]
Opening Paragraphs + Extract:
People who survive polio in childhood will not suffer further effects later in life, say US researchers.
The Mayo Clinic team looked at 50 people who had had the disease as children and found most did not suffer any polio-related decline when older.
Polio has been wiped out in most places but remains a threat, particularly in India, Pakistan and Nigeria.
Experts said the Journal of the Peripheral Nervous System paper offered reassurance to polio survivors.
…
Dr Eric Sorenson, who led the study, said: “Other researchers have suggested that polio is a more aggressive condition later in life, but we’ve actually found it to be relatively benign.
“Our results suggest that polio survivors may not age any differently than those in the normal population – they’re not doing too badly compared to their peers.”
He added that the findings should be comforting to people worried about polio-related decline later in life.
“Though the likelihood is high that patients who have had childhood polio will complain of weakness later in life, they can expect years of stability without the need for major lifestyle modifications.”
———
BBC News | Health | ‘No Polio effects’ in later life.
Last Updated: Saturday, 26 August 2006, 23:55 GMT 00:55 UK.
The full text of the above article can be found at [link opens in new window]
http://news.bbc.co.uk/1/hi/health/4799725.stm.
+++
November 11, 2006
Dr. Sorenson responds to “Polio Survivors throw doubt on Study”. [Part VI – The Author’s Response]
[P&PPNews Editor: Dr. Sorenson’s numbered comments reference corresponding comments in “Polio Survivors throw doubt on Study”. Published with Dr. Sorenson’s permission.]
Dear Ms. Boone,
Thank you for your correspondence and your comments. Many of the points you raised are valid criticisms. I would make the following comments:
The study population was chosen to be a random, population based sample. This was done because this method of sampling is the least biased. There are always questions about whether or not: A) the sample cases are representative of the population from which they are drawn, and B) is the population that is sampled, representative of the diseased population as a whole. You mention that our sample is skewed with an over-representation of those more severely affected. Actually, if our sampled is biased it is biased towards those less affected. Approximately 40% of our subjects had only minimal neurological deficits. I’m not sure how you arrived at the 90% being severe. Only about 20% of our subjects would we have classified as severe.
In our study we did find that the polio subjects did weaken modestly with time, but the degree of this weakness did not correlate with whether or not they were symptomatic. The only correlation with symptoms was with the severity of their residual deficits after polio. I am only aware of one other large prospective study on polio from the Netherlands that over a 6 year period found similar results (Nollet F. et. Al. Perceived health and physical functioning in postpoliomyelitis syndrome: a 6-year prospective follow-up study. Archives of Physical Medicine & Rehabilitation. 84(7):1048-56, 2003).
You may very well be correct that there is a subset of subjects that do more poorly than the group as a whole. Our polio cohort, as a whole, was fairly normally distributed in their magnitude of change over the course of the study. The majority of our cohort had only a modest decline in strength, however, there was a small minority that changed more and a small minority that didn’t change at all. In our cohort we did not identify any baseline variables that predicted the rate of change. Predictor variables may exist but we did not identify any.
I am not sure how to comment on this point. We have not presented any data with an intent to mislead or misrepresent.
I do not believe that anyone who sees polio patients questions the existence of the post-polio syndrome. I have not made any such claims. I believe the controversy is over our theory that the normal process of aging may be the root cause. It is true that we did not include a normal aging control group at the onset of our cohort study and this remains our speculation. A normal age matched control group has not been done in any previous long term study of polio survivors that I am aware of. This theory however has been erroneously interpreted that we are suggesting that polio survivors are merely getting older. In contrast, we propose that there is an attritional loss of motor neurons, muscle mass and strength in normal subjects. Because normal subjects have a considerable reserve capacity, they are not aware of these effects. Polio survivors however, who have already lost a number of motor neurons, no longer have that reserve capacity and the same attritional loss in them results in larger problems and progressive weakness. This would explain why those who with the largest residual deficits are more likely to be symptomatic; and why the polio group as a whole appears to decline in a relatively normally distributed fashion.
The issues related to the reliability and validity of MMT are valid. Because of this we did not only complete the MMT but also completed quantitative strength tests using a series of strain gauges resulting in specific force measurements in the muscle groups tested. It is difficult to translate these force measurements into an overall global measure of strength which can be done and has been validated with the NDS-w scale (MMT). In looking at the quantitative force measurements the results were the same as those with the NDS-w scores providing internal validity to our findings.
As you point out responses to questionnaires can be misleading. One of the drawbacks of questionnaire research is the subjectivity and the interpretation of the respondent. We asked a number of questions including specific questions such as: What gait aids do you use? What braces or orthotics do you use? What modifications have you made to your home? Etc. to minimize the subjectivity and variability of the respondents.
You are correct that it is often difficult to assess the extent of polio survivors residual effects by talking to or merely observing them. I am often struck by how polio survivors have adapted to their deficits. This is why it was important that we did our timed functional tasks, strength testing and electrophysiology testing at baseline and followed the group prospectively. Otherwise it is very difficult to determine this in a retrospective fashion. Even our baseline assessments were years after maximal recovery in all cases. What the polio subjects’ true maximal recovery was cannot be known for certain, and must be inferred.
I am sorry if our work has provided you or your colleagues difficulty or distress, none was intended.
Sincerely,
Eric J. Sorenson, MD Department of Neurology Mayo Clinic Rochester, MN 55905
END
Polio Survivors throw doubt on Study | Hilary Boone [PDF 157KB] | Minor Revisions 11th November 2006.
https://www.lincolnshirepostpolio.org.uk/downloads/extra/poliosurvivorsdoubtstudy.pdf
+++
September 23, 2006
Three reviews of ‘Electrophysiological findings in a cohort of old polio survivors’ (E. J. Sorenson, et al). [Part V – The Dissection]
The following articles consist of three separate reviews of the recently published ‘Electrophysiological findings in a cohort of old polio survivors’ [Sorenson EJ, Daube JR and Windebank AJ (2006) Journal of the Peripheral Nervous System, Vol 11:241-246].
In “MUNE data review”, Dr. Mavis Matheson discusses significant inconsistencies in the math. “I’ve reviewed the article and if the math is done correctly, one gets entirely different results.”
MUNE data review | Dr. Mavis Matheson [PDF 102KB].
https://www.lincolnshirepostpolio.org.uk/downloads/extra/munedatareview.pdf
In the second article “The Mayo Clinic haunts postpolio patients again”, Dr Ruth Bridgens discusses a number of aspects including the cohort’s applicability to the wider population of polio survivors, the limitations of the measures chosen and the interpretation of their findings.
The Mayo Clinic haunts postpolio patients again | Dr Ruth Bridgens [PDF 149KB] | Updated 26th September 2006.
https://www.lincolnshirepostpolio.org.uk/downloads/extra/mayohauntsagain.pdf
Finally, in the third and last article of this set, “Polio Survivors throw doubt on Study”, Hilary Boone has applied a retrospective comparative analysis to all the major articles arising from this study published over its 15 year period. Based on that analysis, seven issues are raised which “we believe need to be taken into account before conclusive statements can be made regarding findings from Sorenson et al s research report.”
Polio Survivors throw doubt on Study | Hilary Boone [PDF 157KB] | Updated 11th November 2006.
https://www.lincolnshirepostpolio.org.uk/downloads/extra/poliosurvivorsdoubtstudy.pdf
+++
November 11, 2006
Dr. Sorenson responds to “Polio Survivors throw doubt on Study”. [Part VI – The Author’s Response]
[P&PPNews Editor: Dr. Sorenson’s numbered comments reference corresponding comments in “Polio Survivors throw doubt on Study”. Published with Dr. Sorenson’s permission.]
Dear Ms. Boone,
Thank you for your correspondence and your comments. Many of the points you raised are valid criticisms. I would make the following comments:
The study population was chosen to be a random, population based sample. This was done because this method of sampling is the least biased. There are always questions about whether or not: A) the sample cases are representative of the population from which they are drawn, and B) is the population that is sampled, representative of the diseased population as a whole. You mention that our sample is skewed with an over-representation of those more severely affected. Actually, if our sampled is biased it is biased towards those less affected. Approximately 40% of our subjects had only minimal neurological deficits. I’m not sure how you arrived at the 90% being severe. Only about 20% of our subjects would we have classified as severe.
In our study we did find that the polio subjects did weaken modestly with time, but the degree of this weakness did not correlate with whether or not they were symptomatic. The only correlation with symptoms was with the severity of their residual deficits after polio. I am only aware of one other large prospective study on polio from the Netherlands that over a 6 year period found similar results (Nollet F. et. Al. Perceived health and physical functioning in postpoliomyelitis syndrome: a 6-year prospective follow-up study. Archives of Physical Medicine & Rehabilitation. 84(7):1048-56, 2003).
You may very well be correct that there is a subset of subjects that do more poorly than the group as a whole. Our polio cohort, as a whole, was fairly normally distributed in their magnitude of change over the course of the study. The majority of our cohort had only a modest decline in strength, however, there was a small minority that changed more and a small minority that didn’t change at all. In our cohort we did not identify any baseline variables that predicted the rate of change. Predictor variables may exist but we did not identify any.
I am not sure how to comment on this point. We have not presented any data with an intent to mislead or misrepresent.
I do not believe that anyone who sees polio patients questions the existence of the post-polio syndrome. I have not made any such claims. I believe the controversy is over our theory that the normal process of aging may be the root cause. It is true that we did not include a normal aging control group at the onset of our cohort study and this remains our speculation. A normal age matched control group has not been done in any previous long term study of polio survivors that I am aware of. This theory however has been erroneously interpreted that we are suggesting that polio survivors are merely getting older. In contrast, we propose that there is an attritional loss of motor neurons, muscle mass and strength in normal subjects. Because normal subjects have a considerable reserve capacity, they are not aware of these effects. Polio survivors however, who have already lost a number of motor neurons, no longer have that reserve capacity and the same attritional loss in them results in larger problems and progressive weakness. This would explain why those who with the largest residual deficits are more likely to be symptomatic; and why the polio group as a whole appears to decline in a relatively normally distributed fashion.
The issues related to the reliability and validity of MMT are valid. Because of this we did not only complete the MMT but also completed quantitative strength tests using a series of strain gauges resulting in specific force measurements in the muscle groups tested. It is difficult to translate these force measurements into an overall global measure of strength which can be done and has been validated with the NDS-w scale (MMT). In looking at the quantitative force measurements the results were the same as those with the NDS-w scores providing internal validity to our findings.
As you point out responses to questionnaires can be misleading. One of the drawbacks of questionnaire research is the subjectivity and the interpretation of the respondent. We asked a number of questions including specific questions such as: What gait aids do you use? What braces or orthotics do you use? What modifications have you made to your home? Etc. to minimize the subjectivity and variability of the respondents.
You are correct that it is often difficult to assess the extent of polio survivors residual effects by talking to or merely observing them. I am often struck by how polio survivors have adapted to their deficits. This is why it was important that we did our timed functional tasks, strength testing and electrophysiology testing at baseline and followed the group prospectively. Otherwise it is very difficult to determine this in a retrospective fashion. Even our baseline assessments were years after maximal recovery in all cases. What the polio subjects’ true maximal recovery was cannot be known for certain, and must be inferred.
I am sorry if our work has provided you or your colleagues difficulty or distress, none was intended.
Sincerely,
Eric J. Sorenson, MD Department of Neurology Mayo Clinic Rochester, MN 55905
END
Polio Survivors throw doubt on Study | Hilary Boone [PDF 157KB] | Minor Revisions 11th November 2006.
https://www.lincolnshirepostpolio.org.uk/downloads/extra/poliosurvivorsdoubtstudy.pdf
Electrophysiological findings in a cohort of old polio survivors Read More »
Hilary Boone and Dr Sorenson
Lancet
Study Throws Doubt on PPS
Dr Windebeck
Correspondence Boone with Sorenson Read More »
Polio Survivors Throw Doubt on Study
Hilary Boone, Lincolnshire Post-Polio Network
‘Survivors of childhood polio do well decades later as they age’ [a],
‘Polio Survivors faring well’ [b],
‘‘No polio effects’ in later life’ [c]
The above three press statements were made in sequence during the last ten days of August 2006. The initial statement, on the 21st August 2006, was the announcement by the Newsbureau of the Mayo Clinic in Rochester, Minnesota, [a] of the research findings reported in an article in the Journal of the Peripheral Nervous System, ‘Electrophysiological findings in a cohort of old polio survivors’ by Eric J. Sorenson, Jasper R. Daube, and Anthony J. Windebank. Their research used a cohort of patients that they had been studying over the last 15 years. [1,2,3,3a,4,5] A cohort of 50, reduced over the 15 years to 38 ‘old polio survivors’. Within days the findings had been reported by other media and by the time it was on the BBC News – Health there were ‘No polio effects in later life’. [c]
Polio Survivors who are NOT doing well decades after recovery; who do have polio effects in later life; who have been presenting with well documented new symptoms – including considerable functional decline in actions of daily living – to recognised Post Polio Clinics and Specialists during the last 25 years are once again disappointed that this cohort continues to be used as representative of the polio population. In the authors’ own words in the 1996 article ‘…we believe that our findings can be extrapolated to the whole population of polio survivors in the United States.’[4]
McCarthy reviewed the 1996 article [4] in the Lancet in February 1996 [8] with the heading
Study throws doubt on post polio syndrome
Helena Edwards of the Leicestershire Post-Polio Network in her rebuttal stated, ‘We, in the UK, heard from people whose doctors were assuring them that PPS did not exist, and in some cases the doctors mentioned that their information came from an article they had read recently.’ [9]
We present the following issues that we believe need to be taken into account before conclusive statements can be made regarding findings from Sorenson et al’s research report. Authors who raise other issues with this research, and the way findings have been presented, are included in References at the end of this paper [d,e,f,g].
population’, because 90% of their cohort is towards one end of the scale, towards
more severe deficits.
to have been dismissed when in fact they appear to show what is happening at the
other end of the scale, those of us presenting to PPS specialists and PPS Clinics;
polio survivors who recovered well and now have new symptoms and considerable
functional decline in activities of daily living.
from previous articles.
the normal population, then appear to proceed to ‘overcome’ or ‘ignore’ them in this
article. Yet just eighteen months earlier they stated ‘the effects of normal aging in this
cohort cannot be commented on.’ [5]
you do x?” and the vast majority will say “Yes”. Ask the same number “How do you do
x?” and you are likely to get a huge variety of answers.
often not realised.
Issue 1
Quite simply, in the authors own words, from two of the articles, the cohort used is weighted towards people whose polio residuals were more visible
Rochester and the surrounding area’ [2]
deterioration and those who were not.’ This intentionally biases the study toward
those with difficulty… At this time, 31 patients have completed the study.’ [2]
was likely to stay in the area and be available for follow-up study.’’ [3]
closer to our clinic.’ [3]
on the basis of their having had polio.’ [3]
Issue 2
Important facts in their study actually relate to the other end of the scale, of polio survivors who are experiencing new symptoms and functional decline, do not seem to have been given equal attention. Again using the authors own words. [3]
difficulties’
leg weakness was a surgeon. He had significant progressive leg weakness so that
ambulation had deteriorated from requiring no aids to needing a cane and then a
walker and finally a wheelchair for distances’
acute illness were in 4 subjects.
Three of the four had purely bulbar polio but now complained of limb symptoms. The fourth had paralysis involving the legs and now complained of arm pain’
evidence of having been affected by the original disease.’
Issue 3
The use of numbers and phrases in their articles can easily be misinterpreted without reading all previous articles relating to the study. For instance the article that triggered the recent press releases, ‘Electrophysiological findings in a cohort of old polio survivors’, stated:-
documented history of paralytic poliomyelitis residing in Olmsted County at the time of
the infection. [6]
Compare that statement with the following quotes from the progression of articles from 1984 to 2005, referenced [1,2,3,4,5], relating to this study group. We accept that these quotes are taken in isolation and not the full context, but they do not appear to be consistent.
1984 Patients were required to have had established residence in Rochester prior to diagnosis for inclusion in this study.’
‘Of the 316, 201 had paralytic polio and 115 had nonparalytic polio.’
‘23 died in the acute phase of the illness…. 7 deaths in subsequent years.’
… ‘a questionnaire was circulated in April 1984 to all traceable patients who had had paralytic poliomyelitis.’
‘Of 171 potential respondents… 23 people remain untraced at the time of presentation of this data’
‘Replies have been received from 128.., three persons were unwilling to participate.’ ‘Of the 125 remaining, 97 patients indicated stability and 28 indicated deterioration since their maximal recovery from polio.’
‘This questionnaire was supplemented by a detailed telephone interview for those who indicated deterioration since their maximal functional recovery from polio.’ [1]
1987 ‘This group has subsequently been expanded to include all residents of Olmstead
County, who had paralytic polio between 1935 and 1959. Two hundred eighty six subjects were identified, and 276 have been located for follow-up.
‘Thirty people (10.5%) died in the acute phase of the illness, and 23 died in later years.’
‘The remaining 233 formed the cohort for the follow-up. Two hundred twenty-three have been located’.
‘At this time, 31 patients have completed the study. Ten individuals reported no difficulties of any kind… Seventeen reported new, perceived, specific limb weakness.’ [2]
1991 ‘We identified a cohort of 300 individuals who had paralytic polio between 1935 and 1955. All lived in Olmstead County, Minnesota.’
‘Two hundred ninety-three of the 300 cases were traced. Of the 300 subjects, 53 were known to have died’.
‘Fifty survivors who lived closest to Rochester were selected for the study. This group was likely to stay in the area and be available for follow-up study.’
‘58 subjects were called in order to recruit 50.’
In response to the questionnaire, 32 individuals complained of some new difficulty (Table 4)
Table 4 – No new symptoms 18. *Types of complaints reported by 32 of the subjects with paralytic polio.
More subjects (21 of 33) complained of lower limb difficulty than upper limb problems (nine of thirty)
The cause of the symptoms is unclear but they are not attributable to age alone because the population is still relatively young (median age 49 years) [3]
1995 ‘Of the 300 cases, 298 identified for follow-up. 53 had died;’
‘From the population of 300, 50 survivors were chosen on the basis of proximity of residence to Rochester. This group was chosen because they were likely to stay in the area and be available for detailed repeated measurements.’
‘Detailed comparisons between 50 and the other 197 survivors to ensure that the cohort was representative.’
‘This group of subjects was then reconstructed after five years. All gave information about their present status, and 46 underwent again the complete battery of tests described above.’
‘The number of subjects reporting new symptoms of weakness, pain, or fatigue remained constant over the five year interval. Of 30 individuals who had symptoms at the first study point, 23 continued to have symptoms and 7 did not. Six individuals who did not have symptoms at the first time point did have symptoms after five years.’
‘..(Table 1), the distribution remained similar except that more patients were likely to be complaining of all three symptoms at the second evaluation.’ [3a]
1996 ‘Three hundred individuals met the criteria for paralytic poliomyelitis. 298 of whom were available for follow-up; (n.b. 53 had died) we chose a representative cohort of 50 individuals for prospective, sequential evaluations. They were chosen because they represented the whole cohort…’
‘Of the 50 patients, 46 completed the detailed 5 year study. Four patients declined to complete the tests but were contacted by telephone; all four reported that they were asymptomatic and did not want to participate in further detailed physiologic testing.’’ [4]
2005 ‘In 1987, we began a population-based cohort study of 50 subjects with a remote history of paralytic poliomyelitis.’
‘Fifty representative subjects were chosen from 298 patients who previously had well documented paralytic poliomyelitis, living in Olmstead County at the time of the infection.’ (n.b. 53 had died)
Of the original 50 subjects of the cohort, three subjects died during the 15 year follow up period. Nine of the remaining 47 refused further participation.’
‘Thirty-one of the 38 subjects whom we followed for 15 years reported symptoms of progressive weakness during the study period. Only seven subjects remained asymptomatic.’ [5]
Issue 4
Sorenson et al make several statements of caution when comparing their study to others then appear to proceed to ‘overcome’ or ‘ignore’ them. E.g. Regarding the McComas study Sorenson states ‘Without such a control group, one cannot reliably compare the changes in the polio group with those in a normal aging population.’ [6]
The first paragraph of their Press Release on 21st August 2006 states:-
‘Survivors of Childhood Polio Do Well Decades Later As They Age’
ROCHESTER, Minn. Mayo Clinic researchers have found that years after experiencing childhood polio, most survivors do not experience declines greater than expected in their elderly counterparts, but rather experience only modest increased weakness which may be commensurate with normal aging.’ [a]
Compare that to the statement in their 15 year follow-up article published in March 2005, just eighteen months earlier.
‘How the changes identified in our polio cohort compare with those of a normal aging population remains unknown. We did not include a normal control group at the inception of the cohort. In the absence of a normal control population, the effects of normal aging in this cohort cannot be commented on.’[5]
Issue 5
Manual Muscle Testing – How valid and reliable is this as a form of grading muscles?
Professor W.J.W. Sharrard – a world renowned Polio Professor from the 1950’s, who wrote ‘Muscle recovery in Poliomyelitis’ [10], studied polio patients at autopsy and found that ‘muscle grades of 3 were given to individuals with 85% denervation of the muscles. In other words, profound muscle weakness must be evident before abnormal grades are given.’
The Mayo Clinic states that Manual Muscle Testing and Isometric testing across different joints were used to grade muscles. They have not used the normal MRC grading scale but used the following scale, which they state ‘has the advantage that numbers can be handled additively for additional analysis’ [2]
0 Normal strength
1 25% loss of strength
2 50% loss of strength
3 75% loss of strength
4 100% loss of strength
The issue with Manual Muscle Testing – most often performed as a single action – is that it will not tell the health professional how long the patient can sustain that action, repeat that action, or how they use that action in a pattern of movement. According to Westbrook in her rebuttal of the 5 year study [9] Windebank et al derived their “Neurological Disability Score” from the results of manual muscle testing, a method that is notorious for overestimating polio muscle strength.[11] Polio survivors developed many trick movements; use other muscles instead of or to assist weakened ones. Important evidence of reported new weakness and compensatory strategies can be missed unless people are observed performing actions of daily living over a period of time.
Polio Survivors, who have often taken months or even years before presenting new weakness to a health professional, report again and again that ‘They say I am strong, that I have nothing wrong with me. Then why can I no longer do the things I used to a few years ago?’ To ensure this is not misinterpreted as age loss; such comments are coming from individuals in their 40’s and 50’s. The following are two responses to the Lincolnshire Post-Polio Network in May 2002:
“Regarding the MMT you are correct. If done only a single time, it can give an erroneous idea of the true muscle strength and endurance. In a way, the key word here is “endurance” which reflects muscle strength on multiple contractions. Many polios will have good strength on a single contraction only to get weaker on repeated contractions.” Lauro S. Halstead M.D. Director of Post-Polio Program, National Rehabilitation Hospital, Washington DC, USA.
“You have done a brilliant job of describing a real problem for polio survivors and professionals that is, the limitations of the Manual Muscle Testing (MMT) scheme (a British invention, circa 1950, by the way). I quite agree with your comments and observations”. Fred Maynard, M.D. Marquette, Michigan, USA – President Board of Directors, Post-Polio Health International.
Issue 6
Each participant completed a questionnaire of 337 items enquiring about limb and bulbar weakness, pain, fatigue and activities of daily living, in a YES/NO format.
There is an issue here that is well recognised and reported on in medical articles, [12] that polio survivors are strong willed, determined, highly capable people, who, regardless of level of disability/ability, do not need any help thank you. They are reluctant to admit that they are having new symptoms, new functional decline, and even when admitted and/or confirmed by testing, it can still be some time before they take the advice to pace and rest and use aids and equipment. Using a yes/no questionnaire does not necessarily allow polio survivors to convey to the health professional HOW they actually perform the action in question. ‘Independently and with ease’ for ‘I could/can manage a small flight of stairs (about 10 steps) might turn out to be going up backwards sitting on their bottom.
Sorenson et al recognised ‘that it had been difficult to ascertain whether limbs, apparently uninvolved by the original disease process, might become affected by progressive symptoms years later. This is because of the reliance of the memories of an illness that occurred 30 to 50 years earlier.’
The mean age at polio onset was variously reported as 9, 12 or 13 with the youngest age at one year or less. Not only is it difficult for affected individuals and family members to remember, it must also be taken into account that the youngest patients had limited language levels at the time of their polio.
Issue 7
The high levels of recovery from Paralytic Polio of some polio survivors, including some who were in iron lungs, is often not realised. Many have competed in professional or high level amateur sports, some have joined the police and armed forces, or had other highly physical jobs. The damage from their polio was not easily visible externally.
Following a presentation at St. Thomas Hospital in London by Dr. Windebank on the results of the first five years study [4], Hilary Boone asked “How many of the 50 did sport?” Dr. Windebank replied that “one man could manage three holes of golf.” When asked, ‘No swimmers, athletes, rugby referees, people in the police or armed forces?’ he emphatically replied, ‘these people had paralytic polio’. Hilary Boone replied, ‘so did the people I am talking about, including myself. They all had paralytic polio and some were even in iron lungs’. The seminar restarted and Dr. Windebank did not answer a follow-up letter.
Conclusion
We believe the above throws doubt on the methods used in this study and the conclusions the authors made and continue to make from this research. The cohort steered towards those
on the basis of their having had polio’ [Discussion 1991 – 3]
It is highly possible that this cohort is not representative of the 608 residents of Olmstead County who had acute polio between 1935 and 1960. The results of the 50, now 38, people in this study cannot be extrapolated to the polio population of the United States. Sorenson et al’s conclusions, based on a study of patients who have been chosen/selected, without a control group, believed by them to be representative of the ‘polio population’, can in fact be misleading.
Sorenson et al state, ‘There are no confirmatory tests to reliably distinguish between the effects of the old disease from new progressive difficulties. It is a clinical diagnosis following history taking, physical examination, and test results.’ [3] Therefore we believe it is essential that any study group mentioned in a polio/post polio medical article is more clearly defined to allow readers to make comparisons with their patients.
More and more polio survivors who recovered to the greatest degree from paralytic polio are now presenting to health professionals with new symptoms of weakness, pain, fatigue and considerable functional decline in actions of daily living. These are people who have often led active lives, have competed at amateur and professional sports, and who have had highly physically demanding jobs. They now find they have to:-
In fact the results of this study can and should only be compared to those polio survivors who match the level of ability, disability, symptoms and lifestyle of the 50 participants, now 38.
This cohort has also been used in another article in Neurology in 2005. [7]
Where do we go from here?
Terminology: Are reported symptoms related to the late effects of polio, post polio syndrome, post polio sequelae, unstable polio, post-polio muscular atrophy, another medical condition; or a combination?
To be perfectly frank Polio Survivors already experiencing new and unexpected symptoms and functional decline do not care what label they are given so long as:-
The Mayo Clinic have been aware for ten years since publishing the results of the 5 year level of their study that other health professionals and post polio support groups do not entirely agree with all the statements made regarding their Olmstead County Polio research. It is regrettable that following such critique, they did not extend their study to include more polio survivors who had recovered like the surgeon and were now experiencing considerable new difficulties.
It is a sorry state of affairs when polio survivors around the world must give up hours of their time to research their medical condition. To have to continually question and research the results of testing that do not corroborate your reported symptoms because of the way it has been carried out or recorded is unjust. Struggling on year after year, often deteriorating through incorrect advice and treatment or lack of it, has to come to an end.
Polio Survivors – a strong willed, determined, highly motivated, hard working group of people – want to live for as long as possible, doing as much as possible. We need a full and accurate base line assessment that takes into account the endurance of our weakening muscles. We need advice, and the understanding that it takes time to accept that we have to change our lifestyle. We need treatment where it is available, appropriate aids and equipment, and benefits so that we can financially cope in this world where anything ‘disabled’ has a high price label.
References – available from PSN on request admin@poliosurvivorsnetwork.org.uk
Polio Survivors Throw Doubt on Study Read More »
Information Surrounding Article from
Mayo Clinic Causes Frustration
Apress release from Mayo Clinic (Rochester, Minnesota) this
August was entitled “Survivors of childhood polio do well decades later as they age.” The release summarized the work published in the September 2006 Journal of the Peripheral Nervous System (Volume 11, Issue 3). “Electrophysiological findings in a co hort of old polio survivors” by Eric J. Sorenson, Jasper R. Daube and Anthony J. Windebank, reported on a randomly selected group of 50 polio survivors from the general population of Olmsted County, home of Mayo Clinic, they followed for 15 years. The average age of participants at the study’s start was 53, and the patients were an average of 40 years past their childhood experience with polio.
Martin B. Wice, MD, Chair of PHI’s Medical Advisory Committee, reminds all of us that the effect of a small loss of strength can dramatically affect some survivors’ ability to func tion. It has to do with the starting point. He explains, “If Warren Buffet loses 10% of his income, he
The technical conclusions from the abstract were that “overtime, the co hort demonstrated a modest decline in summated compound muscle action potential amplitudes (CMAP) and a moderate decline in the summated motor unit number estimates (MUNE). There was no association between symptoms of late deterioration and magnitude of decline. Rather, the presence of these symptoms was asso ciated with the magnitude of the residual deficits. Two patterns of neu ron loss were modeled (linear and proportional decline). The summated MUNE was a more sensitive measure of loss of motor units than was the summated CMAP and appears to be a more valid measure of attritional loss of anterior horn cells. Of these two models of neuron loss, the proportional loss of motor neurons was a better fit of the data than a linear loss.”
Headlines read, “No polio effects in later life” and “Problems attributed to aging.” A Post-Polio Health reader
was “outraged that … post-polio syn drome was trivialized. My muscle wasting, weakness and tremor in my left hand and arm, in addition to atrophy in my right leg, is not part of the normal aging process.”
When questioned, Eric J. Sorenson, MD, responded, “Unfortunately, our work has been interpreted that the
post-polio syndrome doesn’t exist. The point is that the majority of sur vivors of childhood polio do well for many years. There is a small minority, and we saw this in our population as well, that may follow a more aggres sive course. Most polio survivors fol lowed a relatively stable path with time over 15 years.
“The issue with aging is difficult. We did not include a normal aging group with our cohort and so we cannot draw any firm conclusion in that regard. The magnitude of change we saw in the cohort appeared to be commensurate with what would be expected in normal aging, however, there was a wide range. Some changed very little; some changed more. This is good news for the majority. Our work is not intended to diminish the significant problems that do occur in some polio survivors, but rather reassure the many worried polio survivors that they are not nec essarily destined for progressively increasing disability as they age.” s
won’t notice, but if some one who earns $15,000 a year loses 10% of their
earnings, it will have a major impact on what they eat.”
Want to read more?
Go to www.post-polio.org/ipn/ mayo.html.
“Aging Brings New Challenges for Polio Survivors” by Mike Mitka in JAMA, October 11, 2006, Vol. 256, No. 14, www.jama.com.
www.post-polio.org POST-POLIO HEALTH B Fall 2006 B Vol. 22, No. 4 3
Information Surrounding Article from Mayo Clinic Causes Frustration Read More »